Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429 , pp. 1 - 14 [Scientific article]Open Access
Rizzo A.; Dadduzio V.; Ricci A.D.; Massari F.; Di Federico A.; Gadaleta-Caldarola G.; Brandi G., Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2022, 31, pp. 371 - 378 [Scientific article]
Rizzo A.; Ricci A.D.; Cusmai A.; Acquafredda S.; De Palma G.; Brandi G.; Palmiotti G., Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future, «CURRENT ONCOLOGY», 2022, 29, pp. 551 - 564 [Scientific article]Open Access
Brandi G.; Di Federico A.; Rizzo A.; De Lorenzo S.; Vasuri F.; Brocchi S.; Golfieri R.; Morelli M.C.; Frega G.; Palloni A., The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma, «ANTI-CANCER DRUGS», 2022, 33, pp. e781 - e783 [Scientific article]
Rovesti G.; Leone F.; Brandi G.; Cesario S.; Scartozzi M.; Niger M.; Yoo C.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Bernardini L.; Cho H.; Lai E.; Fenocchio E.; Pircher C.; Iacono D.; De Lorenzo S.; Sperti E.; Massa V.; De Braud F.; Jeong J.H.; Aprile G.; Burgio V.; Cascinu S.; Casadei-Gardini A., A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index, «JOURNAL OF GASTROINTESTINAL CANCER», 2021, 1, pp. 1 - 9 [Scientific article]
Filippi R.; Montagnani F.; Lombardi P.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Faloppi L.; Palloni A.; Satolli M.A.; Scartozzi M.; Citarella F.; Lutrino S.E.; Vivaldi C.; Silvestris N.; Rovesti G.; Rimini M.; Aglietta M.; Brandi G.; Leone F., A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy, «ACTA ONCOLOGICA», 2021, 60, pp. 1317 - 1324 [Scientific article]
Massari F.; Di Nunno V.; Guida A.; Costa Silva C.A.; Derosa L.; Mollica V.; Colomba E.; Brandi G.; Albiges L., Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 32 - 40 [Scientific article]
Rizzo A.; Brandi G., Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, Article number: 100334 , pp. 1 - 7 [Scientific article]Open Access
Munoz-Martinez S.; Sapena V.; Forner A.; Nault J.-C.; Sapisochin G.; Rimassa L.; Sangro B.; Bruix J.; Sanduzzi-Zamparelli M.; Holowko W.; El Kassas M.; Mocan T.; Bouattour M.; Merle P.; Hoogwater F.J.H.; Alqahtani S.A.; Reeves H.L.; Pinato D.J.; Giorgakis E.; Meyer T.; Villadsen G.E.; Wege H.; Salati M.; Minguez B.; Di Costanzo G.G.; Roderburg C.; Tacke F.; Varela M.; Galle P.R.; Alvares-da-Silva M.R.; Trojan J.; Bridgewater J.; Cabibbo G.; Toso C.; Lachenmayer A.; Casadei-Gardini A.; Toyoda H.; Ludde T.; Villani R.; Matilla Pena A.M.; Guedes Leal C.R.; Ronzoni M.; Delgado M.; Perello C.; Pascual S.; Lledo J.L.; Argemi J.; Basu B.; da Fonseca L.; Acevedo J.; Siebenhuner A.R.; Braconi C.; Meyers B.M.; Granito A.; Sala M.; Rodriguez-Lope C.; Blaise L.; Romero-Gomez M.; Pinero F.; Gomez D.; Mello V.; Pinheiro Alves R.C.; Franca A.; Branco F.; Brandi G.; Pereira G.; Coll S.; Guarino M.; Benitez C.; Anders M.M.; Bandi J.C.; Vergara M.; Calvo M.; Peck-Radosavljevic M.; Garcia-Juarez I.; Cardinale V.; Lozano M.; Gambato M.; Okolicsanyi S.; Morales-Arraez D.; Elvevi A.; Munoz A.E.; Lue A.; Iavarone M.; Reig M., Assessing the impact of COVID-19 on liver cancer management (CERO-19), «JHEP REPORTS», 2021, 3, pp. 1 - 9 [Scientific article]Open Access
Rizzo A.; Ricci A.D.; Brandi G., Atezolizumab in advanced hepatocellular carcinoma: Good things come to those who wait, «IMMUNOTHERAPY», 2021, 13, pp. 637 - 644 [Scientific article]
Marinaccio A.; Consonni D.; Mensi C.; Mirabelli D.; Migliore E.; Magnani C.; Di Marzio D.; Gennaro V.; Mazzoleni G.; Girardi P.; Negro C.; Romanelli A.; Chellini E.; Grappasonni I.; Madeo G.; Romeo E.; Ascoli V.; Carrozza F.; Angelillo I.F.; Cavone D.; Tumino R.; Melis M.; Curti S.; Brandi G.; Mattioli S.; Iavicoli S., Authors’ response: Mezei et al's "comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis", «SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH», 2021, 47, pp. 87 - 89 [Comment or similar]
Rizzo A.; Ricci A.D.; Brandi G., Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma, «LIVER CANCER», 2021, 11, pp. 180 - 181 [Scientific article]Open Access
Rizzo A.; Brandi G., BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 483 - 485 [Comment or similar]
Rizzo A.; Brandi G., Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, Article number: 100328 , pp. 100328 - 100334 [Scientific article]Open Access
Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G., Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis, «JOURNAL OF CHEMOTHERAPY», 2021, 1, pp. 1 - 10 [Scientific article]
